At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines" title="" class="btn" data-container="body" data-html="true" data-id="229538" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Astellas Pharma"> 528,192 42,723 42,723
Sectors
Location
Nihombashi Astellas Mitsui Bldg., 2-chōme-5-1 Nihonbashihonchō, Chuo City, Tokyo 103-0023, Japan
Chuo City
Japan
Engaged entities
133Added in Motherbase
17 Jul 2024, 2:43 p.m.Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world.
At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines
Pharmaceuticals and 医薬品
Astellas Home page | Astellas Pharma Inc.
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | PharmaVoice Pharmaceutical Manufacturing | Other 13 Nov 2024 | | |
![]() | Octopize Security and Investigations, it services, privacytech | Other 30 Nov 2024 | | |
![]() | Autolomous it services, deeptech | Other 14 Nov 2024 | | |
![]() | MyData-TRUST - Data Protection & Privacy for Life Sciences Business Consulting and Services, privacytech | Other 13 Dec 2024 | | |
![]() | Women In Optometry Wellness and Fitness Services, edtech | Other 6 Nov 2024 | | |
![]() | AviadoBio biotech, deeptech | Other 18 Jan 2025 | | |
![]() | Capital.gr Facilities Services | Other 22 Oct 2024 | | |
![]() | Association Trans-Forme entertainment, healthtech | Other 25 Nov 2024 | | |
![]() | Deep Knowledge Analytics Research Services, it services | Other 31 Aug 2024 | | |
![]() | Hurdle Biotechnology Research, biotech, deeptech | Other 30 Sep 2024 | |
As we approach the end of 2024, we reflect on our journey and the partnerships that have helped us shape the future of healthcare. At Astellas, we are committed to turning innovative science into VALUE for patients, and we are proud of the progress we have made together.
We extend our warmest wishes for joy and health to all our stakeholders this holiday season. Your support and collaboration have been instrumental in our achievements, and we look forward to continuing this important mission together in the year ahead.
#innovation #partnerships #healthcare
We’re proud to share that Astellas has entered into a license agreement with Sangamo Therapeutics, Inc., which will allow us to leverage Sangamo’s novel proprietary neurotropic adeno-associated virus (#AAV) capsid, STAC-BBB, to deliver gene therapies to treat certain #NeurologicalDiseases.
This agreement reinforces our ongoing commitment to the gene therapy field and turning innovative science into VALUE for patients.
Learn more:
https://lnkd.in/g9hsJV-x
In a landscape where many pharmaceutical companies are calling for a return to the office, Astellas is taking a bold step in the opposite direction. Our Chief People Officer and Chief Ethics & Compliance Officer, Katsuyoshi Sugita, recently shared insights on how our commitment to a flexible working environment is not just a trend—it's a strategy for attracting and retaining top talent.
At Astellas, we trust our employees to deliver results, whether they work in the office once a year, once a quarter or every day. This flexibility is a key factor in attracting individuals with a patient-first mindset who thrive in a transformative environment.
Kats also emphasizes the importance of preserving the unique cultures of acquired companies, fostering innovation and ownership. As we continue to grow, we remain dedicated to creating a workplace where each culture is respected, and talents can flourish.
Read full article:
https://lnkd.in/gtNSHxdv
HR Executive #FlexibleWork #TalentAttraction #pharmaceuticals
At Astellas, we recognize that fostering robust partnerships with ambitious innovators across pharma, biotech, academia and beyond is essential for advancing #ScientificInnovation in today’s complex landscape.
Issei Tsukamoto, Head of Business Development, emphasizes how our unique approach to collaboration can accelerate the delivery of #TransformativeTherapies to patients, sooner.
Please read the full article to gain insights into how we are building dynamic and flexible partnerships and how we are working to bring groundbreaking science to fruition.
https://lnkd.in/gDGTQu7a
We are proud to launch our second Astellas Healthcare E-city in Brazil. This innovative digital experience delivers health information, education, and support about vasomotor symptoms during menopause to reach Brazilians in urban and rural communities. Visitors can also navigate to the first E-city with gastric cancer resources.
This is the latest milestone in our commitment to improving Access to Health as we collaborate with external partners to help strengthen health systems and improve healthcare literacy.
Learn more:
https://bit.ly/4gjMLVM
#AccessToHealth #HealthcareInnovation #HealthLiteracy